Table 1.
Genetic abnormalities commonly detected in combination with t(8;21).
| Abnormality | Frequency in t(8;21) AML | Documented prognostic impact | Reference |
|---|---|---|---|
| Chromosomal abnormalities | |||
| -X in female patients | 30%–40% | None | [7, 24, 25] |
| -Y in male patients | 50%–60% | Possible improved | [7, 24, 25] |
| Del(9q) | 15%–35%; most studies state 15%–20% | None | [7, 24–26] |
| Trisomy 8 | 8% | [27] | |
| Complex abnormalities | 9%–23% | Adverse prognosis | [27–29] |
| Molecular abnormalities | |||
| KIT mutations | 25%–50% | Possible adverse prognosis | [30–41] |
| JAK2V617F | 6%–8% | [36, 42] | |
| Flt3 -ITD | 5% | Adverse prognosis | [24, 33, 43] |
| Flt3 D853 | 3%–7% | [24, 43] |